MiNK Therapeutics, Inc. Stock Issued During Period, Value, Employee Benefit Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- MiNK Therapeutics, Inc. stock issued during period, value, employee benefit plan for the quarter ending 2026-03-31 was $481.23K.
- MiNK Therapeutics, Inc. stock issued during period, value, employee benefit plan for the quarter ending 2025-09-30 was $370.57K.
- MiNK Therapeutics, Inc. stock issued during period, value, employee benefit plan for the quarter ending 2023-06-30 was $187.38K, a 37.44% increase year-over-year.
- MiNK Therapeutics, Inc. stock issued during period, value, employee benefit plan for the quarter ending 2023-03-31 was $346.34K.
- MiNK Therapeutics, Inc. stock issued during period, value, employee benefit plan for fiscal 2025 was $370.57K.
- MiNK Therapeutics, Inc. stock issued during period, value, employee benefit plan for fiscal 2023 was $533.72K, a 291.50% increase from fiscal 2022.
- MiNK Therapeutics, Inc. stock issued during period, value, employee benefit plan for fiscal 2022 was $136.33K.
| Period end | Stock Issued During Period, Value, Employee Benefit Plan 3 month | Stock Issued During Period, Value, Employee Benefit Plan 12 month |
|---|---|---|
| 2026-03-31 | $481.23K 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $370.57K 10-K · filed 2026-03-31 | |
| 2025-09-30 | $370.57K 10-Q · filed 2025-11-14 | |
| 2023-12-31 | $533.72K 10-K · filed 2025-03-18 | |
| 2023-06-30 | $187.38K 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $346.34K 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $136.33K 10-K · filed 2024-03-21 | |
| 2022-06-30 | $136.33K 10-Q · filed 2023-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |